【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hemophilia Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users, by region / by product / by country
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.2. Rising neonatal population driving diagnostic rate
3.7.3. Favorable government initiatives
3.7.4. Rising R & D and new product development
3.7.5. Rising adoption for prophylaxis treatment
3.7.6. Market Restraint Analysis
3.7.7. High cost of treatment
3.7.8. Industry Challenges
3.7.9. Low adoption rate to advanced technologies
3.8. Hemophilia: Market Analysis Tools
3.8.1. Industry Analysis – Porter’s
3.8.1.1. Supplier Power: (Low)
3.8.1.2. Buyer Power: (Moderate)
3.8.1.3. Substitution Threat: (Moderate)
3.8.1.4. Threat from new entrant: (Moderate)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
Chapter 4. Hemophilia Market: Segment Analysis, By Type, 2015 – 2026 (USD Million)
4.1. Definitions & Scope
4.2. Type market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Hemophilia Market, by Type, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Hemophilia A
4.5.2. Hemophilia B
4.5.3. Hemophilia C
4.5.4. Others
Chapter 5. Hemophilia Market: Segment Analysis, By Treatment, 2015 – 2026 (USD Million)
5.1. Definitions & Scope
5.2. Type market share analysis, 2018 & 2026
5.3. Segment Dashboard
5.4. Global Hemophilia Market, by Treatment, 2015 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
5.5.1. Replacement therapy
5.5.2. ITI therapy
5.5.3. Gene therapy
Chapter 6. Hemophilia Market: Segment Analysis, By Therapy, 2015 – 2026 (USD Million)
6.1. Definitions & Scope
6.2. Type market share analysis, 2018 & 2026
6.3. Segment Dashboard
6.4. Global Hemophilia Market, by Therapy, 2015 to 2026
6.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
6.5.1. On-demand
6.5.2. Prophylaxis
Chapter 7. Hemophilia Market: Regional Market Analysis, 2015 – 2026 (USD Million)
7.1. Definitions & Scope
7.2. Regional market share analysis, 2018 & 2026
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.5. Regional Market Share and Leading Players, 2018
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
7.6.1. North America
7.6.2. Europe
7.6.3. Asia Pacific
7.6.4. Latin America
7.6.5. Middle East & Africa
7.7. Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
7.8. North America
7.8.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.8.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.8.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.8.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.8.5. U.S.
7.8.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.8.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.8.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.8.6. Canada
7.8.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.8.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.8.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9. Europe
7.9.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.9.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.5. Germany
7.9.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.6. UK
7.9.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.7. France
7.9.7.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.7.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.7.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.8. Italy
7.9.8.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.8.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.8.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.9.9. Spain
7.9.9.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.9.9.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.9.9.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10. Asia Pacific
7.10.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.10.1.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.1.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.1.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.2. China
7.10.2.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.2.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.2.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.3. Japan
7.10.3.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.3.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.3.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.4. India
7.10.4.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.4.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.4.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.5. Thailand
7.10.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.10.6. South Korea
7.10.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.10.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.10.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11. Latin America
7.11.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.11.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.5. Brazil
7.11.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.6. Mexico
7.11.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.7. Argentina
7.11.7.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.7.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.7.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.11.8. Columbia
7.11.8.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.11.8.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.11.8.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12. Middle East and Africa
7.12.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.12.2. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.3. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.4. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12.5. South Africa
7.12.5.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.5.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.5.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12.6. Saudi Arabia
7.12.6.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.6.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.6.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
7.12.7. UAE
7.12.7.1. Market estimates and forecast, by type, 2015 – 2026 (USD Million)
7.12.7.2. Market estimates and forecast, by treatment, 2015 – 2026 (USD Million)
7.12.7.3. Market estimates and forecast, by therapy, 2015 – 2026 (USD Million)
Chapter 8. Hemophilia Market – Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2018
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company Market Share/Ranking, by region
8.4.3. Competitive Dashboard Analysis
8.4.3.1. Market Differentiators
8.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
8.5. Private Companies
8.5.1. List of key emerging companies’ /technology disruptors/innovators
8.5.2. Funding Outlook (Optional)
8.5.3. Regional network map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.6. Supplier Ranking
8.7. Key companies profiled
8.7.1. Novo Nordisk
8.7.1.1. Company Overview
8.7.1.2. Financial Performance
8.7.1.3. Product Benchmarking
8.7.1.4. Strategic Initiatives
8.7.2. Biogen.
8.7.2.1. Company Overview
8.7.2.2. Financial Performance
8.7.2.3. Product Benchmarking
8.7.2.4. Strategic Initiatives
8.7.3. Chugai Pharmaceutical
8.7.3.1. Company Overview
8.7.3.2. Financial Performance
8.7.3.3. Product Benchmarking
8.7.3.4. Strategic Initiatives
8.7.4. Bayer Healthcare
8.7.4.1. Company Overview
8.7.4.2. Financial Performance
8.7.4.3. Product Benchmarking
8.7.4.4. Strategic Initiatives
8.7.5. Pfizer.
8.7.5.1. Company Overview
8.7.5.2. Financial Performance
8.7.5.3. Product Benchmarking
8.7.5.4. Strategic Initiatives
8.7.6. Shire Plc
8.7.6.1. Company Overview
8.7.6.2. Financial Performance
8.7.6.3. Product Benchmarking
8.7.6.4. Strategic Initiatives
8.7.7. Baxalta (Baxter Healthcare)
8.7.7.1. Company Overview
8.7.7.2. Financial Performance
8.7.7.3. Product Benchmarking
8.7.7.4. Strategic Initiatives
8.7.8. CSL Behring.
8.7.8.1. Company Overview
8.7.8.2. Financial Performance
8.7.8.3. Product Benchmarking
8.7.8.4. Strategic Initiatives
8.7.9. Octapharma.
8.7.9.1. Company Overview
8.7.9.2. Financial Performance
8.7.9.3. Product Benchmarking
8.7.9.4. Strategic Initiatives
Chapter 9. KOL Commentary
Chapter 10. Recommendations
【レポート販売概要】
■ タイトル：血友病の世界市場：タイプ別（血友病A、血友病B、血友病C）、治療別（オンデマンド療法、予防投与）、治療別（補充療法、遺伝子治療）、セグメント予測■ 英文：Hemophilia Market Analysis by Type (Hemophilia A, Hemophilia B, Hemophilia C), by Treatment (On-demand, Prophylaxis), by Therapy (Replacement Therapy, Gene Therapy), And Segment Forecasts, 2019 - 2026
■ 発行日：2019年2月25日
■ 調査会社：Grand View Research
■ 商品コード：GVW903090
■ 調査対象地域：グローバル
- 輸送パッケージングの世界市場：段ボール箱、パレット、木枠About Transit Packaging Transit packaging involves protected transportation and handling of goods in large quantities from manufacturing centers to distribution centers, where they are packaged for the customers. Transit packaging products include corrugated boxes, pallets, crates, cases, cushions, foam and are suitable for numerous applications in the electrical and electronic, chemical, pharmace …
- 自然言語処理（NLP）の世界市場2015-2019About NLP Natural language processing is a computer application that can understand human language. It is a part of AI. It is a computerized technique in which human communication is analyzed and interpreted based on a set of theories and technologies by the computer. It is both based on text and speech provided to the computer. Currently, NLP approaches are based on machine learning that uses pat …
- 砕石術デバイスの世界市場予測（～2023年）“The lithotripsy devices projected to grow at a CAGR of 4.5% during the forecast period.”The global lithotripsy devices market is expected to reach USD 1.76 billion by 2023 from USD 1.41 billion in 2018, at a CAGR of 4.5%. Factors driving the growth of this market include the increasing incidence of urolithiasis and technological advancements in lithotripsy devices. On the other hand, unfavorable …
- 世界における小型自動車用アクセス・セキュリティ市場（2008-2028）This latest just-auto report edition offers a global review of the OE vehicle access, anti-theft and security sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE vehicle access, anti-theft and security market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of …
- プレバイオティクス成分の世界市場予測：オリゴ糖、イヌリン、ポリデキストロースThe prebiotic ingredients market is projected to grow at a CAGR of 11.6%, in terms of value, from 2017 to reach a projected value of USD 6.91 Billion by 2022. The market is driven by the demand from Asia-Pacific and Europe. Multi-functional nature of prebiotic ingredients, ease of incorporation in a wide range of applications, and increase in health consciousness among the consumers are the factor …
- 呼吸器ケア装置の世界市場予測（～2021年）：呼吸器治療装置（人工呼吸器、マスク、PAP装置、吸入器、ネブライザー）、呼吸器モニタリング装置、呼吸器検査装置、消耗品The respiratory care devices market is expected to grow at a lucrative CAGR of 9.7% from 2016 to 2021, to reach USD 24.07 billion by 2021 from USD 15.14 billion in 2016. Market growth can be attributed to a number of factors such as high prevalence of respiratory diseases, rapid growth in the aging population, the high prevalence of smoking, rising urbanization and pollution levels, increasing inc …
- 角膜移植片拒絶反応(Corneal Graft Rejection)：治療薬開発パイプライン動向（2015年上半期版）Corneal Graft Rejection - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Corneal Graft Rejection - Pipeline Review, H1 2015’, provides an overview of the Corneal Graft Rejection’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Corneal Graft Rejection, complete with comparative analysis at various stages, therapeutics assessment b …
- イーアクスル（E-Axle）の世界市場：ドライブ種類別（前輪駆動、後輪駆動、および全輪駆動）、コンポーネント別（モーター、パワーエレクトロニクス、トランスミッション、その他）、車両タイプ別（ICE車両（旅客・商用車）、および電気自動車）An electric axle is an integrated system that combines electric motors, power electronics components, and transmission units. It serves as a power source for internal combustion engine type vehicles, and are compatible with hybrid and electric cars. The system is fully integrated into either the front or the rear axle, delivering power to turn the wheels and for other engine-related functions. Mor …
- 世界の薄膜測定システム市場動向（2014～2018）TechNavio's analysts forecast the Global Thin Film Metrology Systems market to grow at a CAGR of 5.02 percent over the period 2013-2018. One of the key factors contributing to this market growth is the high demand for thin film metrology systems for the development of flat panel displays. The Global Thin Film Metrology Systems market has also been witnessing the increased R&D spending by vendors. …
- デジタルテキスタイルプリンターの世界市場：プロセス種類別（衣服直接、生地直接）、用途別（衣料品、アパレル、家具、広告、その他）、機械タイプ別（シングルパス、マルチパス）The global digital textile printing machine market size was $97.6 million in 2017, and is projected to reach $218.3 million in 2025, growing at a CAGR of 10.4%. Digital textile printing machine prints various patterns, or designs directly on the fabric using inkjet technology and a computer software. Factors such as increase in awareness about fashionable clothing, rise in per capita income of ind …
- 透過型電子顕微鏡（TEM）の世界市場2015-2019About Transmission Electron Microscope The capacity of a microscope is limited by the wavelength of the light used. This limitation was particularly felt when the need to study the structure and arrangement of atoms and molecules arose. An electron microscope that uses a beam of accelerated electrons to view objects helps overcome this drawback. Electron microscopes can provide resolution up to 0. …
- Noble Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Noble Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Noble Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- データセンターコロケーションのアジア市場2017-2021About Data Center ColocationData center colocation is a facility for renting rack spaces to host computing servers and storage to other organizations. It provides options such as power, bandwidth, and physical security for continued business operations with better reliability and scalability. Managed colocation is also gaining traction where customers host IT infrastructure, which is managed by th …
- 2型糖尿病：グローバル臨床試験レビュー（2014年上半期）Type 2 Diabetes Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Type 2 Diabetes Global Clinical Trials Review, H1, 2014" provides data on the Type 2 Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type 2 Diabetes. It includes an overview of the trial numbers and their recruitment status as …
- マネージド・セキュリティ・サービスの世界市場2015-2019About Managed Security Services Managed security services refer to services outsourced to third-party providers for maintaining information and network security. MSSPs offer managed anti-virus; security monitoring; network boundary protection that includes managed services for firewalls, IDS, and VPN; content filtering; information security risk assessments; incident management including vulnerabi …
